Gümüşay, Ö. Et Al. 2024. A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer. BREAST CANCER RESEARCH AND TREATMENT , vol.203, no.2 , 197-204.

Gümüşay, Ö., Huppert, L. A., Magbanua, M. J. M., Wabl, C. A., Assefa, M., Chien, A. J., ... Melisko, M. E.(2024). A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer. BREAST CANCER RESEARCH AND TREATMENT , vol.203, no.2, 197-204.

Gümüşay, ÖZGE Et Al. "A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer," BREAST CANCER RESEARCH AND TREATMENT , vol.203, no.2, 197-204, 2024

Gümüşay, ÖZGE Et Al. "A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer." BREAST CANCER RESEARCH AND TREATMENT , vol.203, no.2, pp.197-204, 2024

Gümüşay, Ö. Et Al. (2024) . "A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer." BREAST CANCER RESEARCH AND TREATMENT , vol.203, no.2, pp.197-204.

@article{article, author={ÖZGE GÜMÜŞAY Et Al. }, title={A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancer}, journal={BREAST CANCER RESEARCH AND TREATMENT}, year=2024, pages={197-204} }